MARKET

TTRX

TTRX

Turn Therapeutics Inc
NASDAQ
8.76
-0.43
-4.68%
Opening 15:27 07/09 EDT
OPEN
8.90
PREV CLOSE
9.19
HIGH
9.13
LOW
7.82
VOLUME
178.15K
TURNOVER
--
52 WEEK HIGH
26.50
52 WEEK LOW
2.570
MARKET CAP
260.94M
P/E (TTM)
-64.9852
1D
5D
1M
3M
1Y
5Y
1D
Why Is Turn Therapeutics Stock Trading Higher Today?
Benzinga · 2d ago
Turn Therapeutics advances GX-03 Phase 2 eczema program
TipRanks · 2d ago
Turn Therapeutics announces final Stage 2 design of atopic dermatitis program
TipRanks · 2d ago
Turn Therapeutics Completes Comprehensive Interim Analysis Of Ongoing Adaptive Phase 2 Clinical Trial Evaluating GX-03 For Treatment Of Atopic Dermatitis
Benzinga · 2d ago
Turn Therapeutics expands GX-03 Phase 2 atopic dermatitis trial to full EASI severity spectrum
PUBT · 2d ago
Turn Therapeutics expands GX-03 Phase 2 atopic dermatitis study after interim analysis shows broader efficacy
PUBT · 2d ago
TURN THERAPEUTICS - GX-3 SHOWS CLINICALLY MEANINGFUL EFFICACY IN PATIENTS WITH EASI SCORES 1.1 TO 7
Reuters · 2d ago
Turn Therapeutics Gains Ahead of Release of Dermatitis Drug Data
Dow Jones · 3d ago
More
About TTRX
Turn Therapeutics Inc. is a pharmaceutical and medical device development company built around a proprietary platform of technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.

Webull offers Turn Therapeutics Inc stock information, including NASDAQ: TTRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TTRX stock methods without spending real money on the virtual paper trading platform.